Loading...
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
INTRODUCTION: The prevalence of obesity and obesity-related diseases, including type 2 diabetes mellitus (T2DM), is increasing. Exclusion of the foregut, as occurs in Roux-en-Y gastric bypass, has a key role in the metabolic improvements that occur following bariatric surgery, which are independent...
Na minha lista:
| Udgivet i: | BMJ Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5695522/ https://ncbi.nlm.nih.gov/pubmed/29146657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-018598 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|